NL193267B - Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. - Google Patents

Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.

Info

Publication number
NL193267B
NL193267B NL9000428A NL9000428A NL193267B NL 193267 B NL193267 B NL 193267B NL 9000428 A NL9000428 A NL 9000428A NL 9000428 A NL9000428 A NL 9000428A NL 193267 B NL193267 B NL 193267B
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparation
gelatin capsule
ranitidine hydrochloride
filling containing
containing ranitidine
Prior art date
Application number
NL9000428A
Other languages
English (en)
Other versions
NL9000428A (nl
NL193267C (nl
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of NL9000428A publication Critical patent/NL9000428A/nl
Publication of NL193267B publication Critical patent/NL193267B/nl
Application granted granted Critical
Publication of NL193267C publication Critical patent/NL193267C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL9000428A 1989-02-23 1990-02-22 Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat. NL193267C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8904182 1989-02-23
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NL9000428A NL9000428A (nl) 1990-09-17
NL193267B true NL193267B (nl) 1999-01-04
NL193267C NL193267C (nl) 1999-05-06

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9000428A NL193267C (nl) 1989-02-23 1990-02-22 Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.

Country Status (26)

Country Link
US (1) US5028432A (nl)
JP (1) JP2856817B2 (nl)
KR (1) KR940006271B1 (nl)
AT (1) AT401727B (nl)
AU (1) AU629303B2 (nl)
BE (1) BE1003123A3 (nl)
CA (1) CA2010692C (nl)
CH (1) CH680567A5 (nl)
CY (1) CY1734A (nl)
DE (1) DE4005650C2 (nl)
DK (1) DK170209B1 (nl)
FR (1) FR2643263B1 (nl)
GB (2) GB8904182D0 (nl)
HK (1) HK89493A (nl)
HU (1) HU211930A9 (nl)
IE (1) IE63179B1 (nl)
IL (1) IL93490A (nl)
IT (1) IT1240768B (nl)
LU (1) LU87681A1 (nl)
NL (1) NL193267C (nl)
NZ (1) NZ232642A (nl)
PH (1) PH26972A (nl)
SA (1) SA90100287B1 (nl)
SE (1) SE512412C2 (nl)
ZA (1) ZA901348B (nl)
ZW (1) ZW1790A1 (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06501003A (ja) * 1990-09-13 1994-01-27 スミスクライン・ビーチャム・コーポレイション 非水性液状経口懸濁液
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
JP2005531495A (ja) * 2001-12-21 2005-10-20 シャイア ラボラトリーズ，インコーポレイテッド 高い物理的安定性を有する経口カプセル製剤
EP1592760A4 (en) * 2003-01-31 2009-08-12 Smithkline Beecham Corp AS FIXED DISPERSIONS, COMPOSITIONS
PT1660047E (pt) 2003-08-13 2014-02-27 Biocon Ltd Formulação de dosagem sólida de sais de ácidos gordos em micropartículas para agentes terapêuticos
US9579269B2 (en) 2010-06-23 2017-02-28 Colgate-Palmolive Company Therapeutic oral composition
BR112013015574B1 (pt) 2010-12-20 2018-02-06 Colgate-Palmolive Company Composição não aquosa para cuidado oral contendo ativos de oclusão dentária, método de limpeza dos dentes e escova de dentes
CA2821371A1 (en) 2010-12-20 2012-06-28 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
JP2013545800A (ja) 2010-12-20 2013-12-26 コルゲート・パーモリブ・カンパニー 親水性活性剤、疎水性構造化剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物
US20200038376A1 (en) * 2016-11-01 2020-02-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
BE896711A (fr) * 1982-05-14 1983-09-01 Richter Gedeon Vegyeszet Compositions pharmaceutiques anti-ulceres.
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
KR890001179B1 (ko) * 1983-08-01 1989-04-26 알.피.쉐레르 코오포레이션 지속적으로 방출되는 복용체
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
FR2636532B1 (fr) * 1988-09-20 1993-11-19 Glaxo Group Ltd Compositions pharmaceutiques

Also Published As

Publication number Publication date
ATA42190A (de) 1996-04-15
JP2856817B2 (ja) 1999-02-10
CA2010692A1 (en) 1990-08-23
KR940006271B1 (ko) 1994-07-14
IT1240768B (it) 1993-12-17
AU5007390A (en) 1990-08-30
AT401727B (de) 1996-11-25
NL9000428A (nl) 1990-09-17
CY1734A (en) 1994-05-06
KR900012612A (ko) 1990-09-01
IT9047659A0 (it) 1990-02-22
IE63179B1 (en) 1995-03-22
SE9000625L (sv) 1990-08-24
IE900651L (en) 1990-08-23
SE512412C2 (sv) 2000-03-13
PH26972A (en) 1992-12-28
LU87681A1 (fr) 1991-10-08
FR2643263A1 (fr) 1990-08-24
IL93490A (en) 1994-07-31
CA2010692C (en) 1995-12-12
DE4005650A1 (de) 1990-09-06
BE1003123A3 (fr) 1991-12-03
ZW1790A1 (en) 1991-10-16
AU629303B2 (en) 1992-10-01
IL93490A0 (en) 1990-11-29
IT9047659A1 (it) 1991-08-22
CH680567A5 (nl) 1992-09-30
SA90100287B1 (ar) 1999-08-15
NL193267C (nl) 1999-05-06
DK48090A (da) 1990-08-24
GB2229094B (en) 1993-01-06
GB9004016D0 (en) 1990-04-18
US5028432A (en) 1991-07-02
DK170209B1 (da) 1995-06-19
GB8904182D0 (en) 1989-04-05
HK89493A (en) 1993-09-03
GB2229094A (en) 1990-09-19
NZ232642A (en) 1992-07-28
DE4005650C2 (de) 1999-03-25
JPH03200728A (ja) 1991-09-02
DK48090D0 (da) 1990-02-22
HU211930A9 (en) 1996-01-29
ZA901348B (en) 1991-03-27
FR2643263B1 (fr) 1994-09-16
SE9000625D0 (sv) 1990-02-22

Similar Documents

Publication Publication Date Title
NL193267B (nl) Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.
NL192604B (nl) Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat.
NL194858B (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat in de vorm van microdeeltjes, en een werkwijze voor de bereiding van farmaceutisch preparaat in de vorm van een injecteerbare suspentie van microdeeltjes.
FR2636527B1 (fr) Capsule pour medicaments
DE69011885D1 (de) Auf die Mundschleimhaut aufbringbare Arzneizubereitung.
ATA905997A (de) Pharmazeutische zubereitung, die ein mycophenolatsalz enthält
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
FR2633181B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
NL192819B (nl) Met een hydroxypropylmethylcellulosefilm beklede tablet van ranitidine hydrochloride.
DE3879111D1 (de) Pharmazeutische kautablette mit geschmaksmaskierung.
NL194827B (nl) Thieno-triazolo-diazepinederivaten en farmaceutische preparaten die een dergelijk derivaat bevatten.
NL194431B (nl) Farmaceutische preparaten die ranitidine bevatten.
DK496889A (da) Peptidholdigt farmaceutisk praeparat
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
PT8357T (pt) Embalagem para medicamentos com tampa de capuz
ES2021579B3 (es) Capsulas divisibles en piezas
GB2228922B (en) Packaging drugs
DE68915203D1 (de) Pharmazeutische Mischungen.
DE58905160D1 (de) Pharmazeutische zubereitung.
NL193441B (nl) Farmaceutisch preparaat voor veterinair gebruik.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
NL7812644A (nl) N-koolwaterstofacylaminoalkaancarbonzuren, bereiding en toepassing daarvan, benevens geneesmiddelen, die deze verbindingen bevatten.
DE68912947D1 (de) Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung.
FR2651436B1 (fr) Compositions pharmaceutiques contenant un derive substitue soluble de dextrane.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20100222